Invivyd, Inc.: 5%+ holders

As of November 7, 2026, 7 holders' latest Schedule 13D or 13G filings report owning 5% or more of Invivyd, Inc. The largest reported stake is Janus Henderson Group Plc's, at 12.1%. 25 filings are on record since August 14, 2025 (Schedule 13G/A, November 14, 2025).

Who owns Invivyd, Inc.?

M28 Capital Management LP also filed stake reports on 1 other company ↓

Sell to companies like Invivyd, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Your website Find my buyers

Opens in a new tab. No signup.

Key facts

• Filing 2026-08-14 · Reporting person: Biotechnology Value Fund L P · Sole voting: 0 · Shared voting: 16,031,969 · Sole dispositive: 0 · Shared dispositive: 16,031,969 · SCHEDULE 13G/A, 2026-08-14
• Filing 2026-08-14 · Reporting person: Perceptive Advisors LLC · Sole voting: 0 · Shared voting: 18,490,636 · Sole dispositive: 0 · Shared dispositive: 18,490,636 · SCHEDULE 13G/A, 2026-08-14
• Filing 2026-07-28 · Reporting person: BlackRock, Inc. · Sole voting: 15,974,045 · Shared voting: 0 · Sole dispositive: 16,124,696 · Shared dispositive: 0 · SCHEDULE 13G, 2026-07-28
• Filed 2026-05-15 · Holder: Point72 Asset Management, L.P. · Percent: 0% · SCHEDULE 13G/A
• Filed 2026-05-15 · Holder: RA Capital Management, L.P. · Percent: 7% · SCHEDULE 13G/A

Invivyd, Inc. has 25 Schedule 13D or 13G filings on record since 2025-08-14. 7 holders' latest filing reports 5% or more of common stock, $0.0001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.

Holders

Swipe the table sideways to see every column.

Holding shares or following this stake? See who's behind Invivyd, Inc. and the warning signs.

See Invivyd, Inc.'s free Snapshot Watch Invivyd, Inc.: email me the next time it files something

Free to see. No signup.

Keep reading

More on Invivyd, Inc. and the records around it.

Invivyd, Inc. elsewhere on the record

• Leadership changes Sep 2026
• Who owns it

Companies that share a holder

• M28 Capital Management LP also filed stake reports on 1 other company: CURIS INC (Jan 2026)
• Maverick Capital, Ltd. also filed stake reports on 5 other companies: Infleqtion, Inc. (May 2026), Peabody Energy Corporation (Feb 2026), Curis, Inc. (Nov 2025)
• Soleus Private Equity Fund III, L.P. also filed stake reports on 5 other companies: Prelude Therapeutics Inc (Jul 2026), CALCIMEDICA, INC. (May 2026), Aprea Therapeutics, Inc. (Apr 2026)

Want the whole picture on Invivyd, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Invivyd, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Invivyd, Inc. covers

1. The Short Answer

2. Which Company This Is

3. What They Do, And How The Money Works

4. Who Runs It, And How To Reach Them

5. The Money: Funding, Valuation, Runway

6. Who Pays Them, And Who They Are Up Against

7. Warning Bells

8. Sources

   26 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

Order Full ReportSee a sample report

A real finished report, first screen. Opens in a new tab.

Voting and dispositive power, as filed

Swipe the table sideways to see every column.

The latest filing identifies Invivyd, Inc. by CUSIP 00534A102 and gives its principal executive office as 209 CHURCH STREET, NEW HAVEN, CT 06510 (SCHEDULE 13G/A, 2026-08-14).

What the percentages are based on

The following percentages are based upon a denominator that is the sum of: (i) 294,607,452 Shares outstanding as of April 30, 2026, which is the total number of Shares outstanding as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 14, 2026, and (ii) 1,406,826 Shares underlying certain Pre-Funded Warrants held by the Reporting Persons, as applicable.Bvf Partners L P, SCHEDULE 13G/A, 2026-08-14

Timeline

Swipe the table sideways to see every column.

Questions about who owns Invivyd, Inc.

Who owns Invivyd, Inc.?

On this page, 7 holders' latest ownership filings report 5% or more of Invivyd, Inc.: Janus Henderson Group Plc (12.1%, Schedule 13G/A, filed 2025-11-14), Bvf Partners L P (9.99%, Schedule 13G/A, filed 2026-08-14), Adimab, LLC (7.3%, Schedule 13D/A, filed 2025-12-29), RA Capital Management, L.P. (7%, Schedule 13G/A, filed 2026-05-15) and Maverick Capital, Ltd. (6.7%, Schedule 13G/A, filed 2026-02-13); 2 more are listed above.

Who are the largest shareholders of Invivyd, Inc.?

By the share each holder's latest filing reports, the largest holders of Invivyd, Inc. on this page are Janus Henderson Group Plc (12.1%), Bvf Partners L P (9.99%) and Adimab, LLC (7.3%).

When did Janus Henderson Group Plc buy into Invivyd, Inc.?

The filings give report dates, not purchase dates. The earliest filing from Janus Henderson Group Plc on this page is the Schedule 13G, filed 2025-09-08, reporting 11.6%; its latest, Schedule 13G/A filed 2025-11-14, reports 12.1%.

Is this an audit or a full list?

Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 25 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.

Also on the record for Invivyd, Inc.

Swipe the table sideways to see every column.

Tools for this story

Each opens in a new tab, filled in for Invivyd, Inc.. With no account yet, you sign up free and land on the result.

• Get an alert when Invivyd, Inc. is mentioned again
• Find former Invivyd, Inc. employees to interview
• Verify a claim or statistic

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

All recent stakesThat week's stakes